Furthermore, the results demonstrated that the rs4696480 in TLR2 was associated with a decreased risk of COPD based on heterozygote comparison model (adjusted OR = 0.606, 95% CI = 0.376–0.975, p = 0.039) (Table 4). Here, TLR2 is linked to chronic obstructive pulmonary disease.